🦊/Companies

CellTrack

Madison, US · Founded 2026 · Delaware corporation · 1 known investors

Find your way into CellTrack

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

Founders & leadership

VSVictor Santoro Fernandes
Victor Santoro FernandesinFounder & CEOHe completed his PhD in the Medical Physics Department at the University of Wisconsin-Madison, where he now holds an Entrepreneurial Fellowship and previously served as an ambassador for the Wisconsin Alumni Research Foundation. Before that, he earned a master's degree at the Universidade de São Paulo and worked as a data scientist at Semantix.
RHReinier Hernandez
Reinier HernandezinFounder & Chief Scientific AdvisorHe is an Assistant Professor of Medical Physics and Radiology at the University of Wisconsin-Madison, where he trained as an NSF GRFP fellow and NIH trainee before continuing as a research associate. He also serves as Chief Technology Officer at Archeus Technologies, co-founded RPT Labworks, and previously worked as a scientist at Teva Pharmaceuticals and a research intern at Radboudumc.

Board

RD
Robert DrapeBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$30K disclosed across 1 round · 2026

$30KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Victor Santoro FernandesExecutive Officer, Director
  • Reinier HernandezDirector
  • Robert DrapeDirector
Offering amount
$600K
Amount sold
$30K
Minimum investment
$5K
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2026
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CellTrack do?
CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.
Who are CellTrack's investors?
CellTrack's investors include Gener8tor.
How much funding has CellTrack raised?
CellTrack has disclosed $30K raised across 1 round.
Where is CellTrack headquartered?
CellTrack is headquartered in Madison, US.